We are live on
!
Find out more
BCM
Bayesian Capital Management Portfolio holdings
AUM
$156M
1-Year Est. Return
14.89%
This Fund
S&P 500
This Quarter
Est. Return
+23.96%
1 Year Est. Return
+14.89%
3 Year Est. Return
+106.87%
5 Year Est. Return
+133.82%
10 Year Est. Return
+1,146.09%
AUM
$521M
AUM Growth
+$32.6M
(+6.7%)
Cap. Flow
-$31.4M
Cap. Flow
% of AUM
-6.03%
Top 10 Holdings %
Top 10 Hldgs %
11.92%
Holding
876
New
284
Increased
86
Reduced
155
Closed
349
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$7.2M |
| 2 |
Alibaba
BABA
|
+$7.15M |
| 3 |
Accenture
ACN
|
+$6.96M |
| 4 |
FL
Foot Locker
FL
|
+$6.31M |
| 5 |
Procter & Gamble
PG
|
+$4.82M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$7.91M |
| 2 |
Nike
NKE
|
+$7.89M |
| 3 |
Apple
AAPL
|
+$6.97M |
| 4 |
Mondelez International
MDLZ
|
+$5.33M |
| 5 |
Danaher
DHR
|
+$4.12M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.29% |
| 2 | Consumer Discretionary | 21.31% |
| 3 | Healthcare | 12.92% |
| 4 | Industrials | 9.02% |
| 5 | Consumer Staples | 8.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Pacific Biosciences
PACB
$482M
| $122K | 0.02% |
16,900
-16,994
| -50% | -$123K |
|
|
ZIXI
502
DELISTED
Zix Corporation
ZIXI
| $122K | 0.02% |
17,700
+4,900
| +38% | +$35.1K |
|
503
Archrock
AROC
$5.62B
| $116K | 0.02% |
+11,906
| New | +$114K |
|
|
TLRA
504
DELISTED
Telaria, Inc.
TLRA
| $113K | 0.02% |
+17,800
| New | +$74.3K |
|
|
COOP
505
DELISTED
Mr. Cooper
COOP
| $103K | 0.02% |
+10,742
| New | +$144K |
|
|
ZNGA
506
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $103K | 0.02% |
+19,300
| New | +$92.8K |
|
|
DFRG
507
DELISTED
Del Frisco's Restaurant Group, Inc. Common Stock
DFRG
| $103K | 0.02% |
16,100
+4,000
| +33% | +$31.5K |
|
|
HMHC
508
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $100K | 0.02% |
+13,700
| New | +$123K |
|
509
Ford
F
$55.6B
| $96K | 0.02% |
+10,900
| New | +$93.6K |
|
|
TRVG
510
trivago
TRVG
$397M
| $89K | 0.02% |
+4,115
| New | +$113K |
|
511
NIO
NIO
$10.9B
| $83K | 0.02% |
+16,200
| New | +$115K |
|
512
Hudbay
HBM
$13.5B
| $79K | 0.02% |
+11,000
| New | +$68K |
|
513
Aegon
AEG
$13.6B
| $72K | 0.01% |
+17,511
| New | +$76.5K |
|
|
FINV
514
FinVolution Group
FINV
$949M
| $66K | 0.01% |
17,445
-755
| -4% | -$3.08K |
|
|
AMRS
515
DELISTED
Amyris Inc.
AMRS
| $65K | 0.01% |
+31,300
| New | +$124K |
|
516
Digital Turbine
APPS
$1.38B
| $57K | 0.01% |
+16,343
| New | +$44.9K |
|
517
Option Care Health
OPCH
$3.59B
| $56K | 0.01% |
+6,940
| New | +$91.3K |
|
|
IMGN
518
DELISTED
Immunogen Inc
IMGN
| $52K | 0.01% |
+19,060
| New | +$82.6K |
|
519
Northern Oil and Gas
NOG
$2.78B
| $45K | 0.01% |
+1,640
| New | +$41K |
|
520
Stagwell
STGW
$2.17B
| $38K | 0.01% |
+16,783
| New | +$46K |
|
|
AUY
521
DELISTED
Yamana Gold, Inc.
AUY
| $31K | 0.01% |
11,800
-27,500
| -70% | -$71.2K |
|
|
CARM
522
DELISTED
Carisma Therapeutics
CARM
| $23K | ﹤0.01% |
1,134
+434
| +62% | +$7.49K |
|
523
Globalstar
GSAT
$10.6B
| $16K | ﹤0.01% |
2,543
-737
| -22% | -$6.27K |
|
|
VERO
524
DELISTED
Venus Concept
VERO
| $11K | ﹤0.01% |
+7
| New | +$14.3K |
|
|
UPL
525
DELISTED
Ultra Petroleum Corp. Common Stock
UPL
| $9K | ﹤0.01% |
+14,800
| New | +$10.8K |
|
Similar funds
MCM
MFG
AFW
ADBIC
HSM
FWM
PIA
CCP
Bayesian Capital Management's Q1 2019 Portfolio in Review
As of Q1 2019, Bayesian Capital Management held 876 positions worth $521M, up 6.7% from $488M the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Bayesian Capital Management withdrew a net $31.4M in Q1 2019, closing 349 positions and reducing 155 holdings. Its most notable exit was Nike, an estimated $7.89M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 26% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Bayesian Capital Management opened a new position in Micron Technology worth $7.71M.
- Bayesian Capital Management's largest Q1 2019 buy was Micron Technology: 186,500 shares worth $7.71M.
- Bayesian Capital Management added most to Procter & Gamble in Q1 2019, an estimated $4.82M increase.
- Bayesian Capital Management's biggest Q1 2019 reduction was Microsoft, cutting an estimated $7.91M.
- Bayesian Capital Management fully exited Nike in Q1 2019, selling an estimated $7.89M.
- Bayesian Capital Management's ten largest holdings make up 12% of its $521M portfolio in Q1 2019.
- Bayesian Capital Management opened 284 new positions and closed 349 in Q1 2019.
- Bayesian Capital Management's portfolio value rose 6.7% quarter-over-quarter to $521M.
Based on Bayesian Capital Management's 13F filing for Q1 2019, filed 14 May 2019.